Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $147.7500 (0.04%) ($146.0200 - $147.8400) on Thu. Jul. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.49% (three month average) | RSI | 34 | Latest Price | $147.7500(0.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(35%) DIA(26%) SPLV(25%) VYM(24%) XLP(24%) | Factors Impacting ABBV price | ABBV will decline at least -0.745% in a week (0% probabilities). VIXM(-16%) UUP(-13%) TBT(-3%) UNG(-1%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.745% (StdDev 1.49%) | Hourly BBV | -0.8 () | Intraday Trend | 0.3% | | | |
|
Resistance Level | $151.76 | 5 Day Moving Average | $149.67(-1.28%) | 10 Day Moving Average | $150.84(-2.05%) | 20 Day Moving Average | $151.76(-2.64%) | To recent high | -6.8% | To recent low | 7.4% | Market Cap | $260.673b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |